The interplay between mucosal immune responses to natural exposure with mutans streptococci and the incorporation and accumulation of these cariogenic microorganisms in the oral biofilm is unclear. An initial approach to exploring this question would be to assess native secretory immunity emerging as a consequence of Streptococcus mutans infection. To this end, we analyzed salivary IgA antibody to mutans streptococcal glucosyltransferase (Gtf) and glucan binding protein B (GbpB) and to domains associated with enzyme function and MHC class II binding in two experiments. Salivas were collected from approximately 45 day old Sprague-Dawley rats who were then infected with S. mutans SJ32. Infection was verified and allowed to continue for 2-2.5 months. Salivas were again collected following the infection period. Pre-and post-infection salivas were then analyzed for IgA antibody activity using peptide or protein-coated micro-sphere Luminex technology. S. mutans infection induced significant levels of salivary IgA antibody to Gtf (p<0.002) and GbpB (p<0.001) in both experiments, although usually far lower than levels achieved by mucosal immunization. Significantly (p<0.035 to p<0.001) elevated post-infection salivary IgA antibody levels could be detected to 6/10 Gtf peptides associated with either enzyme function or MHC binding. Post-infection antibody levels were also elevated (p<0.031; p<0.001) to two GbpB peptides in the N-terminal region of the six GbpB peptides assayed. Interestingly, the patterns of rodent response to GbpB peptides were similar to those seen in salivas of young children during their initial exposure to S. mutans. Thus, the presence of a detectable post-infection salivary IgA response to mutans streptococcal virulence-associated components , coupled with the correspondence between rat and human mucosal immune responsiveness to naturally presented Gtf and GbpB epitopes, suggests that the rat may be a useful model to define mucosal responses that could be expected in humans. Under controlled conditions of infection, such a model could prove
Introduction
Initial colonization of the human oral cavity by commensal bacteria such as Streptococcus mitis (28, 33) is quickly followed by secretory immune responses to these microorganisms which can be detected in saliva (6, 35). Significant heterogeneity is observed in these early responses (35). As additional oral habitats develop, colonization with a broader spectrum of commensal microorganisms takes place. Each species is likely to induce unique secretory immune responses as well as enhance the response to cross-reacting epitopes already extant. Mutans streptococci, which are strongly associated with dental caries, usually colonize children during the second year of life when oral habitats are more complex (3) . Exposure to these cariogenic streptococci also results in a detectible, though varied, set of secretory immune responses to several of the mutans streptococcal components associated with successful acquisition (34).
The significance of these so-called natural secretory immune responses to members of the oral biofilm is unclear. Cole and co-workers (6) have suggested that a portion of the response is polyclonal and of lower affinity and serves an innate immune-like role of rapid response. It is also likely that adaptive, higher affinity secretory immune responses are also generated during colonization, especially at the outset of colonization. The variety of specificities seen in secretory (salivary) IgA responses to earlier (e.g., S. mitis and Streptococcus salivarius) and later (e.g., Streptococcus mutans) colonizing oral streptococci would support this concept. Some of these natural responses of higher affinity might also modulate the success or duration of colonization.
For example, recent evidence suggests that early formation of salivary IgA antibody to S. mutans glucan binding protein B (GbpB) may delay its colonization in young children who are under heavy challenge with these cariogenic streptococci (25, 26) . The effect of salivary IgA antibody on S. mutans acquisition is compatible with observations that experimental provision of antibody to Rats have frequently been used to explore the effect of increasing the secretory (salivary) immune response by immunization with a variety of putative virulence epitopes on subsequent oral disease, especially dental caries (31) . However, relatively unexplored is the use of this model to study the effect which salivary IgA antibody, naturally induced by infection, may have on the success or extent of colonization with S. mutans. This approach should help us to understand the role of natural immunity in acquisition of these cariogenic streptococci into the human oral biofilm. In order to apply the model in this way, the characteristics of natural salivary IgA immune responses to components associated with adhesion/accumulation of S. mutans following infection alone would be required. In this regard one could follow salivary IgA antibody development to glucosyltransferases (Gtf) and glucan binding protein B (GbpB), as well as intrinsic peptides with putative functional or MHC binding roles, which have also been shown to elicit significant immune responses and, in some cases, protective immunity in experimental models. Such epitopes would include several, sequentially distinct residues within the N-terminal half of glucosyltransferase which are associated with its catalytic activity (8, 9, 16, (22) (23) (24) 42) . Also included would be natural immune responses to regions associated with the ability of Gtf to bind glucan through a series of repeating sequences in the C-terminal third of the molecule (1, 17, 44) . Although functional domains in S. mutans GbpB have not yet been identified, several peptide sequences within its structure (21) have potential for MHC binding.
A C C E P T E D
Thus the purpose of the present investigation was to study the attributes of the natural secretory immune response to S. mutans components important to its colonization through analysis Rat Infection: All rats in the infection studies were challenged with S. mutans strain SJ32 at 48-50 days of age. Rats were placed in tubs (6 rats/ tub), given cariogenic diet 2000 (56% confectioner's sugar), and orally infected with 10 8 streptomycin-resistant S. mutans SJ32 for 3 consecutive days. Rats were again singly caged after the infection protocol was completed and continued on diet 2000 for the duration of the experiment. Infection was verified in all rats after systematic swabbing of rat molars and plating on mitis salivarius (MS) agar and MS agar with streptomycin (MSS) as previously described (41) . In experiment 1, 74 days after infectious challenge, S. mutans represented 22 to 93% (median 39%) of the total streptococcal flora. In experiment 2, 62 days after infectious challenge, S. mutans represented 30 to 88% (median 57%) of the total streptococcal flora. Post-infection salivas were collected 65 (experiment 2) or 79
(experiment 1) days after initial challenge with S. mutans.
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Group comparisons: Pre-and post-infection salivas from experiment 1 (N=11) and experiment 2 (N=11) were used for measurement of salivary IgA antibody to Gtf, Gtf peptides and GbpB.
Salivas were also analyzed for salivary IgA antibody to GbpB peptides. Since many of the salivas from experiment 1 and all salivas from experiment 2 were depleted, a total of 13 pre-and postinfection salivas from two additional experiments (infected day 50; salivas collected 52-59 days later) with similar sham-immunization and S. mutans infection protocols were screened together with 5 pre-and post-infection salivas from experiment 1 for antibody to GbpB peptides (N=18). Protein Preparations: S. mutans strain SJ23 GbpB and S. sobrinus strain 6715 Gtf were prepared as previously described (32, 40) . The S. mutans GbpB was homogeneous in Western blots. The S.
Animals for immunization experiment:
sobrinus Gtf preparation contained a mixture of Gtf isotypes of which approximately 30% was GTF-I which shares greater than 80% homology with S. mutans GtfB and GtfC. S. sobrinus Gtf-S isotypes comprised the balance of the Gtf preparation.
Peptides: Peptide constructs were synthesized by AnaSpec, San Jose, CA, as multiple antigenic peptides (MAP), using the stepwise solid phase method of Merrifield on a core matrix of lysines, yielding macromolecules with four identical peptides as previously described (39). Six monoepitopic peptide construct sequences (QGQ, VAR, SYI, QAA, ANY and SIG) were based on predicted human MHC Class II epitopes (11), that were contained within the GbpB sequence, using the ProPred algorithm (30) . Three monoepitopic peptide construct sequences (pep 7, pep11, Total salivary IgA relative to a standard rat saliva was measured in a separate plate by incubating a 1/2,000 dilution of saliva with beads coated with affinity purified goat antibody to rat IgA (United States Biological, Swampscott, MA). This reaction was detected with monoclonal mouse anti-rat IgA and then with phycoerythrin-goat anti-mouse IgG, as described above.
A C C E P T E D
Individual salivary post-infection IgA antibody FI's were considered positive if they were greater than the mean pre-infection FI + 2 SD for the group, when assayed against the respective peptide-or protein-coated beads. Results are reported as median fluorescence intensity (FI) divided by the total IgA concentration. Gtf was measured in pre-and post-infection salivas after which the antibody activity (reported as fluorescence intensity: FI) was normalized for individual salivary IgA concentration. As presented in Table 2 , the mean increase in IgA antibody activity to Gtf after two-month exposure to S.
mutans was greater than ten-fold (p<0.002) in both experiments. Figure 2 depicts the fold-increase in salivary IgA antibody (FI/IgA) to Gtf for both experiments. Appreciable variation was observed in the ability of rats to mount a mucosal immune response to infection. However, 7/11 salivas in experiment 1 and 10/11 rats in experiment 2 contained levels of IgA antibody to Gtf that were greater than the mean + 2 SD of reactivity of all salivas tested against BSA. Thus, infection was usually sufficient to induce a detectable mucosal immune response to Gtf, under the conditions of infection and analysis used.
Salivary IgA antibody reactivity with GbpB following S. mutans infection. Salivary IgA antibody to GbpB/IgA was also measured in the pre-and post-infection salivas of experiments 1 and 2. Table 2 shows that, despite appreciable variation in FI/IgA antibody levels among rats, significant (p<0.001) increases in IgA antibody activity to GbpB were observed after two-month exposure to S. mutans. Figure 3 presents the fold-increases in salivary IgA antibody (FI/IgA) to GbpB for each saliva in both experiments. More than half of the post-infection salivas (6/11 salivas in experiment 1 and 8/11 rats in experiment 2) contained levels of IgA antibody to GbpB that were greater than the mean + 2 SD of reactivity of all salivas tested against BSA. Thus,
on December 18, 2017 by guest http://iai.asm.org/ Downloaded from infection was also sufficient to induce a detectable mucosal immune response to GbpB in many animals. Interestingly, the correspondence between salivas that had significant post-infection responses to both Gtf and GbpB was 59%.
Salivary IgA antibody reactivity with Gtf-or GbpB-derived peptides following infection.
Gtf peptides: Since infection with S. mutans resulted in the appearance of salivary IgA antibody to Gtf and to GbpB in many animals, it was of interest to identify the respective molecular epitopes to which natural mucosal IgA antibodies would be induced. To this end, the pre-and post-infection salivas of all rats in experiments 1 and 2 were assayed for IgA antibody activity against a panel of ten Gtf-derived peptides ( Much of the initially detectable salivary IgA antibody to mutans streptococci in young children is to a relatively small number of components. Interestingly, the "response" can be quite variable with respect to the degree and antigen recognized, even between siblings within the same family who would presumably be exposed to similar infectious doses from the primary caregiver (34).
This variability is similar to that seen in the present animal study in that there was no significant correlation between antibody to Gtf and GbpB among the 22 rats following exposure to a single 

